Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 705.14M | $ 787.65M | $ 587.37M | $ 810.46M | $ 729.26M |
| Gross Profit | $ 693.92M | $ 778.51M | $ 573.25M | $ 799.61M | $ 717.32M |
| Operating Income | $ -475.08M | $ -353.73M | $ -410.19M | $ -30.19M | $ -172.08M |
| EBITDA | $ -353.72M | $ -235.87M | $ -227.76M | $ -5.19M | $ -111.19M |
| Net Income | $ -453.90M | $ -366.29M | $ -269.72M | $ -28.60M | $ -444.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.30B | $ 2.33B | $ 2.00B | $ 2.13B | $ 1.89B |
| Total Assets | $ 3.00B | $ 2.99B | $ 2.53B | $ 2.61B | $ 2.39B |
| Total Debt | $ 1.42B | $ 1.45B | $ 1.37B | $ 1.25B | $ 908.93M |
| Net Debt | $ 1.17B | $ 1.05B | $ 1.09B | $ 381.86M | $ 511.26M |
| Total Liabilities | $ 2.42B | $ 2.60B | $ 1.96B | $ 1.84B | $ 1.65B |
| Stockholders' Equity | $ 588.35M | $ 386.69M | $ 572.89M | $ 771.74M | $ 743.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -546.23M | $ -335.52M | $ -294.47M | $ 12.90M | $ -5.16M |
| Operating Cash Flow | $ -500.95M | $ -307.51M | $ -274.37M | $ 30.80M | $ 35.89M |
| Investing Cash Flow | $ -134.03M | $ -214.13M | $ -262.64M | $ 194.91M | $ 274.48M |
| Financing Cash Flow | $ 478.06M | $ 644.08M | $ -55.30M | $ 245.93M | $ -596.61M |